MorphoSys AG MOR-DE:XETRA

*Data is delayed | EUR
Last | 10:10 AM CEST
65.84quote price arrow up+0.58 (+0.89%)
Volume
26,115
52 week range
60.30 - 125.20

...

Loading . . .
  • Open65.28
  • Day High66.00
  • Day Low64.64
  • Prev Close65.26
  • 52 Week High125.20
  • 52 Week High Date07/21/20
  • 52 Week Low60.30
  • 52 Week Low Date06/02/21

Key Stats

  • Market Cap2,626.13M
  • Shares Out32.76M
  • 10 Day Average Volume221,052.8
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-29.82

KEY STATS

  • Open65.28
  • Day High66.00
  • Day Low64.64
  • Prev Close65.26
  • 52 Week High125.20
  • 52 Week High Date07/21/20
  • 52 Week Low60.30
  • 52 Week Low Date06/02/21
  • Market Cap2,626.13M
  • Shares Out32.76M
  • 10 Day Average Volume221,052.8
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-29.82

RATIOS/PROFITABILITY

  • EPS (TTM)-5.39
  • P/E (TTM)-12.22
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
MorphoSys AG develops and commercializes antibodies for therapeutic applications. The Company develops drugs using its own research and development, as well as in cooperation with pharmaceutical and biotechnology partners. The Company's operating segments include Proprietary Development and Partnered Discovery. In the Proprietary Development segment, it develops therapeutic antibodies and peptides in the area of inflammatory disease and oncology. In the Partnered Discovery...
Jean-Paul Kress M.D.
Chief Executive Officer
Sung Lee
Chief Financial Officer
Address
Semmelweisstr. 7
Planegg
82152
Germany